Prospects for using risk scores in polygenic medicine

Area of Science:

• Genetics
• Genomics
• Neuroscience

Background:

• Genome-wide association studies (GWAS) have advanced the identification of common genetic variations linked to diseases.
• Individual genetic variants typically have small effect sizes, limiting their utility for precise disease risk prediction.
• Polygenic risk scores (PRS) aggregate effects from numerous genetic variants.

Purpose of the Study:

• To evaluate the potential of polygenic risk scores for clinical translation.
• To explore the predictive capacity of PRS in complex traits and diseases, particularly neuropsychiatric disorders.

Main Methods:

• Leveraging data from genome-wide association studies.
• Developing and applying polygenic risk score methodologies.
• Analyzing the predictive performance of PRS across diverse complex traits.

Main Results:

• Polygenic risk scores demonstrate significant predictive ability for a spectrum of complex traits.
• PRS show particular promise in predicting risk for neuropsychiatric disorders.
• The aggregation of thousands of genetic variants enhances predictive power compared to single variants.

Conclusions:

• Polygenic risk scores represent a promising tool for risk stratification in complex diseases.
• Further research is warranted to optimize PRS for robust clinical implementation.
• The translation of PRS into clinical practice could enhance personalized medicine approaches for disease prevention and management.